Human BMPR-1A / ALK-3, Fc Tag

Bone morphogenetic protein receptor type-1A (BMPR-1A) is a Type I receptor that complexes with BMP Type II receptors to activate SMAD signaling.  BMPR-1A is a receptor for BMP-2, BMP-4, GDF-5, and GDF-6.  This protein product contains the first 152 amino acids of the extracellular portion of BMPR-1A and can be used to interfere with or neutralize ligand signaling.  The product contains a C-terminus linker (IEGRMD) and an Fc tag (Human IgG1). 

SKU Select size Price Buy
100-214-5ug Mini: 5 ug $79.00 + -
100-214-20ug Std.: 20 ug $226.00 + -
100-214-100ug Value: 100 ug $415.00 + -
100-214-500ug Midgi: 500 ug $1,943.00 + -
100-214-1mg Mg: 1 mg $3,360.00 + -

Alternate Names:  BMP type-1A receptor, Activin receptor-like kinase 3, SKR5, Serine/threonine-protein kinase receptor R5, CD292, BRK‑1                       
Accession Number: P36894    
Description:  Bone morphogenetic protein receptor type-1A (BMPR-1A) is a Type I receptor that complexes with BMP Type II receptors to activate SMAD signaling.  BMPR-1A is a receptor for BMP-2, BMP-4, GDF-5, and GDF-6.  This protein product contains the first 152 amino acids of the extracellular portion of BMPR-1A and can be used to interfere with or neutralize ligand signaling.  The product contains a C-terminus linker (IEGRMD) and an Fc tag (Human IgG1). 
Source:  Genetically modified CHO cells.
Predicted MW:  Dimer, 40.4/80.8 kDa (with 362/724 amino acids)
AA Sequence:  QNLDSMLHGT GMKSDSDQKK SENGVTLAPE DTLPFLKCYC SGHCPDDAIN NTCITNGHCF AIIEEDDQGE TTLASGCMKY EGSDFQCKDS PKAQLRRTIE CCRTNLCNQY LQPTLPPVVI GPFFDGSIRI EGRMDDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
Formulation:  Lyophilized from a sterile (0.2 micron) filtered aqueous solution containing PBS

Product Specifications*
*Lot-specific values for the following specifications are supplied with each production lot on its corresponding COA. 

Specification

Method of Determination

Acceptance Criteria

Purity

Reducing and Non-Reducing SDS-PAGE

>95%

Endotoxin

Kinetic LAL (50% confidence)

≤1 EUs/µg

Biological Activity

Inhibition of human BMP-4-induced alkaline phosphatase production by ATDC5 cells

ED50≤ 120 ng/mL

Preparation and Storage

Country of Origin:  USA         Shipping:  Room temperature              

Storage Prior to Reconstitution:  -20°C

Product Reconstitution:  Sterile water at 0.1 mg/mL    

Instructions:      Centrifuge vial before opening.  Suspend the product by gently pipetting the above recommended solution down the sides of the vial.  DO NOT VORTEX.  Allow several minutes for complete reconstitution.  For prolonged storage, dilute to working aliquots in a 0.1% BSA solution, store at -80°C, and avoid repeat freeze thaws. 


Expiration Date:                      

12 months from date of receipt when stored at -20°C to-80°C as supplied. 

1 month when stored at 4°C after reconstituting as directed.

3 months when stored at -20°C to -80°C after reconstituting as directed.

                                                                                   

THIS PRODUCT IS FOR RESEARCH USE ONLY AND IS NOT FOR USE IN HUMANS!           

 

To receive more information or a bulk quote, email us at quotes@shenandoah-bt.com.

 

Product Datasheets Certificates of Analysis Certificates of Origin
PDS Lot 0618 Lot 0618
SDS    

Related products